Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Animal and Human Data in Pursuit of Vaccine Licensure.

Vaccines·2022
Same author

Estimation of ELISA results using a parallel curve analysis.

Journal of immunological methods·2020
Same author

Systematic review and meta-analysis: the effects of fermented milk with <i>Bifidobacterium lactis</i> CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population.

Therapeutic advances in gastroenterology·2017
Same author

Parallelism in practice: approaches to parallelism in bioassays.

PDA journal of pharmaceutical science and technology·2015
Same author

Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet a for keratoconus and keratectasia: a systematic review and meta-analysis.

The ocular surface·2014
Same author

Nitroglycerin 0.4% ointment vs placebo in the treatment of pain resulting from chronic anal fissure: a randomized, double-blind, placebo-controlled study.

BMC gastroenterology·2013
Same journal

Astaxanthin inhibits platelet-mediated thrombosis via suppression of bidirectional αIIbβ3 signaling.

European journal of pharmacology·2026
Same journal

Repurposing of alogliptin to mitigate experimentally-induced ulcerative colitis and its associated pulmonary injury in rats through regulating inflammatory, necroptotic, and ER stress pathways.

European journal of pharmacology·2026
Same journal

Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis.

European journal of pharmacology·2026
Same journal

4-Octyl itaconate attenuates renal calculi formation by inhibiting ferroptosis and oxidative stress via the Nrf2-HO-1/SLC7A11 axis.

European journal of pharmacology·2026
Same journal

VER155008 rescues cognitive impairment in P301S tauopathy mice by promoting HSPA8-mediated lipophagy.

European journal of pharmacology·2026
Same journal

Okanin alleviates osteoarthritis by suppressing oxidative stress and pyroptosis via Nrf2/HO-1 activation.

European journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Estimating vaccine efficacy using animal efficacy data.

Ann Yellowlees1, Richard H J Perry1

  • 1Quantics Biostatistics, West End House, 28 Drumsheugh Gardens, Edinburgh EH3 7RN, UK.

European Journal of Pharmacology
|March 31, 2015
PubMed
Summary
This summary is machine-generated.

Animal models help predict vaccine efficacy in humans when direct human challenge is not feasible. Precise antibody-protection models in animals are crucial for accurate human vaccine efficacy estimates.

Keywords:
Animal ruleBootstrapConfidence intervalSimulationVaccine efficacy

More Related Videos

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K

Related Experiment Videos

Last Updated: Apr 15, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K

Area of Science:

  • Biostatistics
  • Immunology
  • Preclinical Research

Background:

  • Animal models are essential for predicting human intervention effects, particularly vaccine efficacy, when direct human disease challenge is unethical or infeasible.
  • Current methods use animal data to link antibody levels to protection, then apply this to human vaccination studies to estimate efficacy.

Purpose of the Study:

  • To explain statistical techniques for estimating vaccine efficacy and its precision using animal model data.
  • To highlight the importance of precise antibody-protection relationships in animals for accurate human efficacy predictions.
  • To propose a simulation-based experimental design approach to optimize study power and minimize animal and human testing.

Main Methods:

  • Statistical modeling relating antibody levels to protection probability in animal models.
  • Integration of animal model data with human vaccination study data.
  • Bootstrapping and resampling techniques for estimating confidence intervals of vaccine efficacy.
  • Simulation-based design of experiments using preliminary data.

Main Results:

  • Precise estimation of the antibody-level-to-protection relationship in animals, at levels achievable in humans, is critical for accurate vaccine efficacy estimation.
  • Analytical calculation of study power is not possible due to the non-analytical form of vaccine efficacy confidence intervals.

Conclusions:

  • Accurate prediction of human vaccine efficacy relies on precise animal model data and robust statistical methods.
  • A simulation-based approach to experimental design is recommended to maximize study power and reduce the need for extensive human and animal studies.